Please see full Important Safety Information (ISI) below and at https://www.ziiherahcp.com/#important-safety-information.
INDICATION
ZIIHERA (zanidatamab-hrii) 50 mg/mL for Injection for IV is indicated for the treatment of adults with previously treated, unresectable or metastatic HER2-positive (IHC 3+) biliary tract cancer (BTC), as detected by an FDA-approved test.
This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
WARNING: EMBRYO-FETAL TOXICITY
EXPOSURE TO ZIIHERA DURING PREGNANCY CAN CAUSE EMBRYO-FETAL HARM. ADVISE PATIENTS OF THE RISK AND NEED FOR EFFECTIVE CONTRACEPTION.
Learn about ZIIHERA. Full Prescribing Information including BOXED Warning: https://pp.jazzpharma.com/pi/ziihera.en.USPI.pdf
More at: https://www.ziiherahcp.com
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. For information about adverse events or product complaints related to Jazz Pharmaceuticals’ products, visit www.jazzpharma.com/medicines/drug-safety.
This information is intended for US Healthcare Professionals only. ZIIHERA is a Jazz Pharmaceuticals brand and is not associated with any individual users on LinkedIn.
Privacy Notice: https://bit.ly/48EyZKz.
US-ZAN-2400100 Last Updated 11/24.
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://ziiherahcp.com/
- Keywords
- Corona del Mar.
Ziihera® (Zanidatamab-Hrii) For Us Hcps Questions
Ziihera® (Zanidatamab-Hrii) For Us Hcps's website is https://ziiherahcp.com/
Ziihera® (Zanidatamab-Hrii) For Us Hcps's LinkedIn profile is https://www.linkedin.com/company/ziiherahcp
Ziihera® (Zanidatamab-Hrii) For Us Hcps's industry is
Pharmaceutical Manufacturing
Ziihera® (Zanidatamab-Hrii) For Us Hcps's top competitors are
Vena Interventional Corporation,
Naji For Medical Devices & Supplies,
Foshan Null-Space Flight Technology Co.,ltd,
Biogen,
Simplicity Energy Solutions,
Rise Medical,
Haolang Medical Corporation,
Stryker,
Keep Massachusetts Beautiful (Nonprofit),
Axsome Therapeutics, Inc..
Ziihera® (Zanidatamab-Hrii) For Us Hcps's categories are Pharmaceutical Manufacturing
